Loss of RUNX3 is significantly associated with advanced tumor grade and stage in endometrial cancers.Published in:Molecular Medicine Reports, 2018, v. 17, n. 6, p. 8173, doi. 10.3892/mmr.2018.8915By:Jeong, Dongjun;Kim, Hyungjoo;Ryu, Aeli;Sunwoo, Jaegun;Choi, Seung Do;Nam, Gye Hyun;Jeon, SeobPublication type:Article